ICD-10-CM Codes
C00-D49 Neoplasms
D3A-D3A Benign neuroendocrine tumors
D3A- Benign neuroendocrine tumors
2022 ICD-10-CM Diagnosis Code D3A.093

2022 ICD-10-CM Diagnosis Code D3A.093

Benign carcinoid tumor of the kidney

2016

2017

2018

2019

2020

2021

2022

Billable/Specific Code

D3A.093 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2022 edition of ICD-10-CM D3A.093 became effective on October 1, 2021.
This is the American ICD-10-CM version of D3A.093 - other international versions of ICD-10 D3A.093 may differ.

The following code(s) above D3A.093 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to D3A.093:

C00-D49
2022 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Neoplasms
D3A
ICD-10-CM Diagnosis Code D3A
Benign neuroendocrine tumors
Code Also
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Type 2 Excludes
- benign pancreatic islet cell tumors (D13.7)
Use Additional
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.0)
Benign neuroendocrine tumors

Approximate Synonyms

Benign carcinoid of bilateral kidneys
Benign carcinoid of kidney
Benign carcinoid of left kidney
Benign carcinoid of right kidney
Benign carcinoid tumor kidney
Benign carcinoid tumor of left kidney
Benign carcinoid tumor of right kidney
Benign carcinoid tumor, bilateral kidneys
Benign neuroendocrine tumor kidney
Benign neuroendocrine tumor of kidney

ICD-10-CM D3A.093 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):

656 Kidney and ureter procedures for neoplasm with mcc
657 Kidney and ureter procedures for neoplasm with cc
658 Kidney and ureter procedures for neoplasm without cc/mcc
686 Kidney and urinary tract neoplasms with mcc
687 Kidney and urinary tract neoplasms with cc
688 Kidney and urinary tract neoplasms without cc/mcc

Convert D3A.093 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change

Code annotations containing back-references to D3A.093:

Type 1 Excludes: D30.0

ICD-10-CM Diagnosis Code D30.0
Benign neoplasm of kidney
Type 1 Excludes
- benign carcinoid tumor of the kidney (D3A.093)
- benign neoplasm of renal calyces (D30.1-)
- benign neoplasm of renal pelvis (D30.1-)

Diagnosis Index entries containing back-references to D3A.093:

Tumor - see also Neoplasm, unspecified behavior, by site
- carcinoid D3A.00
  ICD-10-CM Diagnosis Code D3A.00
  Benign carcinoid tumor of unspecified site
  2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
  Applicable To
  Carcinoid tumor NOS
  - benign D3A.00
    ICD-10-CM Diagnosis Code D3A.00
    Benign carcinoid tumor of unspecified site
    2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
    Applicable To
    Carcinoid tumor NOS
    - kidney D3A.093

ICD-10-CM Codes Adjacent To D3A.093

D3A.022 Benign carcinoid tumor of the ascending colon

D3A.023 Benign carcinoid tumor of the transverse colon

D3A.024 Benign carcinoid tumor of the descending colon

D3A.025 Benign carcinoid tumor of the sigmoid colon

D3A.026 Benign carcinoid tumor of the rectum

D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion

D3A.09 Benign carcinoid tumors of other sites

D3A.090 Benign carcinoid tumor of the bronchus and lung

D3A.091 Benign carcinoid tumor of the thymus

D3A.092 Benign carcinoid tumor of the stomach

D3A.093 Benign carcinoid tumor of the kidney

D3A.094 Benign carcinoid tumor of the foregut, unspecified

D3A.095 Benign carcinoid tumor of the midgut, unspecified

D3A.096 Benign carcinoid tumor of the hindgut, unspecified

D3A.098 Benign carcinoid tumors of other sites

D3A.8 Other benign neuroendocrine tumors

D37 Neoplasm of uncertain behavior of oral cavity and digestive organs

D37.0 Neoplasm of uncertain behavior of lip, oral cavity and pharynx

D37.01 Neoplasm of uncertain behavior of lip

D37.02 Neoplasm of uncertain behavior of tongue

D37.03 Neoplasm of uncertain behavior of the major salivary glands

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2022 ICD-10-CM Diagnosis Code D3A.093

Benign carcinoid tumor of the kidney

Neoplasms

Benign neuroendocrine tumors

Benign neoplasm of kidney

Benign carcinoid tumor of unspecified site

Benign carcinoid tumor of unspecified site